Rinsho Ketsueki 2011-05-01

[Chronic myelogenous leukemia complicated by drug-induced agranulocytosis].

Takafumi Nakao, Noriko Yoshida, Takahiko Nakane, Yoshiki Terada, Hirohisa Nakamae, Ki-Ryang Koh, Takahisa Yamane, Masayuki Hino

Index: Rinsho. Ketsueki. 52(5) , 278-81, (2011)

Full Text: HTML

Abstract

We describe a patient with chronic myelogenous leukemia (CML) who developed drug-induced agranulocytosis. A 75-year-old female was diagnosed with CML in December 2001. She had been receiving imatinib therapy for more than five years. In August 2007, she was hospitalized due to a severe neutropenia 10 days after colonoscopy. She was diagnosed as having agranulocytosis induced by colonoscopy premedication including scopolamine butylbromide and flumazenil. Severe neutropenia was resolved by G-CSF treatment without CML progression. Agranulocytosis in patients with CML is rare, but potentially lethal. Here, we report the clinical course in this patient.

Related Compounds

Related Articles:

Chemical genetics reveals a complex functional ground state of neural stem cells.

2007-05-01

[Nat. Chem. Biol. 3(5) , 268-273, (2007)]

Small intestinal contrast ultrasonography for the detection of small bowel complications in Crohn's disease: correlation with intraoperative findings and magnetic resonance enterography.

2015-01-01

[J. Gastroenterol. Hepatol. 30(1) , 86-91, (2014)]

Lymphoid nodular hyperplasia of the terminal ileum can mimic active crohn disease on MR enterography.

2014-10-01

[AJR Am. J. Roentgenol. 203(4) , W400-7, (2014)]

Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.

2007-01-01

[Drugs 67(9) , 1343-57, (2007)]

Colonic distention at CT colonography: randomized evaluation of both IV hyoscine butylbromide and automated carbon dioxide insufflation.

2015-01-01

[AJR Am. J. Roentgenol. 204(1) , 76-82, (2015)]

More Articles...